More on LCTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.17 |
|
|||
| Open | $1.15 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.21 | ||||
| Day Low | $1.14 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 856,248 | ||||
- Lineage Cell Therapeutics updates COR1 corneal cell therapy program
- Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
- Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
- Lineage Cell Therapeutics (LCTX) Misses Q1 EPS by 2c
- Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
- OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
- Canaccord Starts Lineage Cell Therapeutics Inc. (LCTX) at Buy
- Lineage Cell Therapeutics forms scientific advisory board
- Lineage Announces Formation of Scientific Advisory Board
Entities mentioned with LCTX
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
